UNSPSC 51101927: Cloquinate

This classification denotes an antiprotozoal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KI24A9FF7S. European Medicines Agency schedules Cloquinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06747MIG. Cloquinate generally arises in the molecular formula C18H26CLN3.2C9H6INO4S.

UNSPSC 51101927 Cloquinate is a Commodity-tier code for pharmaceutical active ingredients and related compounds. Recent state and local procurement activity under this code shows limited direct relevance; the opportunities posted do not align with cloquinate itself but rather with finished pharmaceutical products and medical supplies. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for supply of Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets, and Seminole County, Florida solicited naloxone and drug deactivation systems through an IFB in June 2026. These opportunities represent state health departments and county public-health agencies acquiring finished medicinal products and overdose-reversal supplies rather than raw pharmaceutical ingredients or compounds such as cloquinate.

The code shows minimal recent activity with direct procurement of cloquinate or chemically equivalent products by state and local jurisdictions. Geographic reach in the recent record spans Illinois and Florida, though the sample is too small to characterize a broader regional or sectoral pattern. No open solicitations for cloquinate itself appear in the current opportunity set; the opportunities listed are closed awards or represent different pharmaceutical commodity codes. Firms evaluating pursuit under this code should confirm that target state and local buyers are actively procuring cloquinate or its direct equivalents, as current visibility suggests the code may see greater federal pharmacy or life-sciences research demand than state and local procurement volume.